The biotechnology industry isn’t backing down, with ETFs like the Direxion Daily S&P Biotech Bull 3x Shares (LABU) gaining over 15% to start the new year. More strength could be ahead as the global economy continues to battle with the Covid-19 pandemic. LABU seeks daily investment results...